https://www.selleckchem.com/pr....oducts/pf-477736.htm
3% vs. 29.6%; p = 0.016). Postoperative morbidity was higher after PD (68.4% vs. 23.5%; p 0.001). OS (p = 0.7 and DFS (p = 0.64) were comparable after adjustment for D2 location and adjuvant therapy rate. EN was performed more in American Society of Anesthesiologists (ASA) stage III/IV patients with tumors 5 cm and was associated with a 5-year OS rate of 84.6%, without any disease recurrences. For D-GISTs, LR should be the procedure of choice due to lower morbidity and similar oncological outcomes compared with PD. In sele
Like
Comment
Share
